Compare NAGE & DYOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAGE | DYOR |
|---|---|---|
| Founded | 1999 | 2025 |
| Country | United States | United States |
| Employees | 117 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.2M | 232.3M |
| IPO Year | N/A | N/A |
| Metric | NAGE | DYOR |
|---|---|---|
| Price | $3.36 | $10.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 667.9K | 15.0K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.51 | N/A |
| Revenue Next Year | $14.58 | N/A |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.29 | $9.87 |
| 52 Week High | $14.66 | $10.47 |
| Indicator | NAGE | DYOR |
|---|---|---|
| Relative Strength Index (RSI) | 41.90 | 54.80 |
| Support Level | $3.35 | $9.93 |
| Resistance Level | $4.04 | $10.10 |
| Average True Range (ATR) | 0.15 | 0.01 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 37.74 | 16.67 |
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Insight Digital Partners II is a blank check company.